Astellas Wins Look At OSI's Books Amid $3.5B Bid
OSI Pharmaceuticals Inc. has agreed to allow Astellas Pharma Inc. to take a limited peek at its books in exchange for the Japanese pharmaceutical giant's promise to temporarily hold off on...To view the full article, register now.
Already a subscriber? Click here to view full article